Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Fabi

Showing results (31-40 of 265) with videos related to

Pageof 27
Sort By:
Current Oncology (Toronto, Ont.)|February 24, 2023
Molecular Profile and Matched Targeted Therapy for Advanced Breast Cancer PatientsRosa Falcone, Pasquale Lombardi, Marco Filetti, et al.
Anticancer Research|May 25, 2004
Testis metastasis as an initial manifestation of an occult gastrointestinal cancerNello Salesi, Alessandra Fabi, Barbara Di Cocco, et al.
Frontiers in Oncology|August 9, 2022
How Dual-Energy Contrast-Enhanced Spectral Mammography Can Provide Useful Clinical Information About Prognostic Factors in Breast Cancer Patients: A Systematic Review of LiteratureFederica Vasselli, Alessandra Fabi, Francesca Romana Ferranti, et al.
Breast (Edinburgh, Scotland)|September 1, 2005
Is anthracycline-based chemotherapy alone adequate for young women with estrogen receptor-positive breast cancer?Paola Papaldo, Serena Di Cosimo, Gianluigi Ferretti, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 7, 2018
Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrationsMatteo Allegretti, Alessandra Fabi, Simonetta Buglioni, et al.
Clinical Neuropharmacology|April 29, 2017
Zonisamide in Brain Tumor-Related Epilepsy: An Observational Pilot StudyMarta Maschio, Loredana Dinapoli, Alessia Zarabla, et al.
Cancer Nursing|December 7, 2016
Adherence to Oral Administration of Endocrine Treatment in Patients With Breast Cancer: A Qualitative StudyLaura Iacorossi, Francesca Gambalunga, Alessandra Fabi, et al.
Professioni Infermieristiche|September 8, 2016
Adherence to hormone therapy in women with breast cancer: a quantitative studyLaura Iacorossi, Francesca Gambalunga, Alessandra Fabi, et al.
Frontiers in Oncology|January 30, 2023
Unusual phylogenetic tree and circulating actionable ESR1 mutations in an aggressive luminal/HER2-low breast cancer: Case reportMatteo Allegretti, Vittoria Barberi, Cristiana Ercolani, et al.
Anticancer Research|April 9, 2013
Single-dose palonosetron and dose-reduced regimen of dexamethasone in preventing nausea and vomiting by anthracycline-including chemotherapy in patients with early breast cancerUmberto Pacetti, Enzo Veltri, Silvia Ileana Sara Fattoruso, et al.
Pageof 27

Showing results (31-40 of 265) with videos related to

Sort By:
Pageof 27
Current Oncology (Toronto, Ont.)|February 24, 2023
Molecular Profile and Matched Targeted Therapy for Advanced Breast Cancer PatientsRosa Falcone, Pasquale Lombardi, Marco Filetti, et al.
Anticancer Research|May 25, 2004
Testis metastasis as an initial manifestation of an occult gastrointestinal cancerNello Salesi, Alessandra Fabi, Barbara Di Cocco, et al.
Frontiers in Oncology|August 9, 2022
How Dual-Energy Contrast-Enhanced Spectral Mammography Can Provide Useful Clinical Information About Prognostic Factors in Breast Cancer Patients: A Systematic Review of LiteratureFederica Vasselli, Alessandra Fabi, Francesca Romana Ferranti, et al.
Breast (Edinburgh, Scotland)|September 1, 2005
Is anthracycline-based chemotherapy alone adequate for young women with estrogen receptor-positive breast cancer?Paola Papaldo, Serena Di Cosimo, Gianluigi Ferretti, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 7, 2018
Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrationsMatteo Allegretti, Alessandra Fabi, Simonetta Buglioni, et al.
Clinical Neuropharmacology|April 29, 2017
Zonisamide in Brain Tumor-Related Epilepsy: An Observational Pilot StudyMarta Maschio, Loredana Dinapoli, Alessia Zarabla, et al.
Cancer Nursing|December 7, 2016
Adherence to Oral Administration of Endocrine Treatment in Patients With Breast Cancer: A Qualitative StudyLaura Iacorossi, Francesca Gambalunga, Alessandra Fabi, et al.
Professioni Infermieristiche|September 8, 2016
Adherence to hormone therapy in women with breast cancer: a quantitative studyLaura Iacorossi, Francesca Gambalunga, Alessandra Fabi, et al.
Frontiers in Oncology|January 30, 2023
Unusual phylogenetic tree and circulating actionable ESR1 mutations in an aggressive luminal/HER2-low breast cancer: Case reportMatteo Allegretti, Vittoria Barberi, Cristiana Ercolani, et al.
Anticancer Research|April 9, 2013
Single-dose palonosetron and dose-reduced regimen of dexamethasone in preventing nausea and vomiting by anthracycline-including chemotherapy in patients with early breast cancerUmberto Pacetti, Enzo Veltri, Silvia Ileana Sara Fattoruso, et al.
Pageof 27